Raymond James Financial Inc Dyne Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 53,093 shares of DYN stock, worth $528,275. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,093
Previous 99,328
46.55%
Holding current value
$528,275
Previous $2.34 Million
76.28%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
218Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$103 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$96.7 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$90.8 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$73.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$73.5 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $515M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...